Truist Financial Corp Vertex Pharmaceuticals Inc Transaction History

Truist Financial Corp

  • $62.9 Billion
  • Q3 2024

A detailed history of Truist Financial Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Truist Financial Corp holds 209,919 shares of VRTX stock, worth $85.7 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
209,919
Previous 218,641 3.99%
Holding current value
$85.7 Million
Previous $102 Million 4.73%
% of portfolio
0.16%
Previous 0.16%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$460.0 - $505.78 $4.01 Million - $4.41 Million
-8,722 Reduced 3.99%
209,919 $97.6 Million
Q2 2024

Aug 20, 2024
SELL
$392.81 - $485.53 $1.76 Million - $2.17 Million
-4,470 Reduced 2.0%
218,641 $102 Million
Q1 2024

May 10, 2024
SELL
$407.69 - $446.08 $915,264 - $1 Million
-2,245 Reduced 1.0%
223,111 $93.3 Million
Q4 2023

Feb 02, 2024
SELL
$343.0 - $410.68 $585,501 - $701,030
-1,707 Reduced 0.75%
225,356 $91.7 Million
Q3 2023

Nov 14, 2023
BUY
$338.18 - $362.46 $19.7 Million - $21.1 Million
58,219 Added 34.48%
227,063 $79 Million
Q2 2023

Aug 01, 2023
BUY
$314.42 - $351.91 $2.56 Million - $2.86 Million
8,141 Added 5.07%
168,844 $59.4 Million
Q1 2023

May 05, 2023
SELL
$283.23 - $323.1 $3.04 Million - $3.47 Million
-10,741 Reduced 6.27%
160,703 $50.6 Million
Q4 2022

Feb 17, 2023
BUY
$285.76 - $321.48 $18 Million - $20.2 Million
62,866 Added 57.9%
171,444 $49.5 Million
Q3 2022

Oct 26, 2022
BUY
$273.83 - $305.53 $476,738 - $531,927
1,741 Added 1.63%
108,578 $31.4 Million
Q2 2022

Jul 22, 2022
SELL
$234.96 - $292.55 $972,029 - $1.21 Million
-4,137 Reduced 3.73%
106,837 $30.1 Million
Q1 2022

Apr 22, 2022
BUY
$221.42 - $260.97 $5.94 Million - $7 Million
26,836 Added 31.9%
110,974 $29 Million
Q4 2021

Feb 14, 2022
BUY
$177.01 - $223.45 $511,027 - $645,100
2,887 Added 3.55%
84,138 $18.5 Million
Q3 2021

Nov 05, 2021
BUY
$181.39 - $202.99 $7.89 Million - $8.83 Million
43,511 Added 115.29%
81,251 $14.7 Million
Q2 2021

Aug 16, 2021
BUY
$187.49 - $221.1 $15,936 - $18,793
85 Added 0.23%
37,740 $7.61 Million
Q1 2021

May 17, 2021
SELL
$207.02 - $241.31 $386,299 - $450,284
-1,866 Reduced 4.72%
37,655 $8.09 Million
Q4 2020

Feb 18, 2021
SELL
$207.01 - $276.09 $578,385 - $771,395
-2,794 Reduced 6.6%
39,521 $9.34 Million
Q3 2020

Nov 05, 2021
BUY
$255.65 - $303.1 $21,730 - $25,763
85 Added 0.2%
42,315 $11.5 Million
Q3 2020

Nov 13, 2020
BUY
$255.65 - $303.1 $700,481 - $830,494
2,740 Added 6.94%
42,230 $11.5 Million
Q2 2020

Nov 16, 2021
BUY
$225.48 - $295.8 $12,175 - $15,973
54 Added 0.14%
39,490 $11.5 Million
Q2 2020

Aug 14, 2020
BUY
$225.48 - $295.8 $1.02 Million - $1.34 Million
4,530 Added 12.98%
39,436 $11.4 Million
Q1 2020

Nov 05, 2021
BUY
$199.77 - $247.81 $10,787 - $13,381
54 Added 0.15%
34,906 $8.31 Million
Q1 2020

May 15, 2020
SELL
$199.77 - $247.81 $63,726 - $79,051
-319 Reduced 0.91%
34,852 $8.29 Million
Q4 2019

Nov 16, 2021
BUY
$166.71 - $223.91 $12,336 - $16,569
74 Added 0.21%
35,171 $7.7 Million
Q4 2019

Feb 14, 2020
BUY
$166.71 - $223.91 $4.25 Million - $5.71 Million
25,503 Added 265.82%
35,097 $7.69 Million
Q3 2019

Oct 31, 2019
BUY
$166.23 - $187.09 $13,797 - $15,528
83 Added 0.87%
9,594 $1.63 Million
Q2 2019

Jul 24, 2019
SELL
$164.61 - $190.37 $28,312 - $32,743
-172 Reduced 1.78%
9,511 $1.75 Million
Q1 2019

Apr 23, 2019
SELL
$163.73 - $194.7 $15,390 - $18,301
-94 Reduced 0.96%
9,683 $1.78 Million
Q4 2018

Jan 22, 2019
SELL
$151.91 - $192.21 $104,058 - $131,663
-685 Reduced 6.55%
9,777 $1.62 Million
Q3 2018

Oct 17, 2018
BUY
$167.73 - $192.74 $17,443 - $20,044
104 Added 1.0%
10,462 $2.02 Million
Q2 2018

Jul 26, 2018
SELL
$145.72 - $169.96 $155,483 - $181,347
-1,067 Reduced 9.34%
10,358 $1.76 Million
Q1 2018

Apr 20, 2018
BUY
$151.6 - $177.13 $34,413 - $40,208
227 Added 2.03%
11,425 $1.86 Million
Q4 2017

Jan 29, 2018
BUY
$137.28 - $155.55 $12,629 - $14,310
92 Added 0.83%
11,198 $1.68 Million
Q3 2017

Oct 23, 2017
BUY
$148.13 - $162.24 $1.65 Million - $1.8 Million
11,106
11,106 $1.69 Million

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
221M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email